Market Overview

FDA's Orange Book Doesn't Include Amarin's Vascepa NCE Status in November Report - Bloomberg

Share:
Related AMRN
12 Biggest Mid-Day Losers For Monday
10 Stocks Moving In Monday's Pre-Market Session

View Orange Book.

Posted-In: News FDA

 

Related Articles (AMRN)

View Comments and Join the Discussion!